What does the presence of leukocytes on a urine dipstick indicate in a pregnant woman and how should it be evaluated and managed?

Leukocytes on Urinalysis in Pregnancy

Leukocytes on urine dipstick in pregnancy are poorly specific and should not be used alone to diagnose or treat urinary tract infections—always obtain a urine culture before initiating antibiotics unless the patient is symptomatic with concerning features.

Clinical Significance and Diagnostic Limitations

Leukocyte esterase on urine dipstick has poor diagnostic accuracy in pregnant women. The test demonstrates a sensitivity of 72-97% but critically low specificity of only 41-86% 1. Recent real-world data from pregnant women shows even worse performance: leukocyte esterase had 75.5% sensitivity but only 40.4% specificity 2. This means that positive results are frequently false positives, leading to unnecessary antibiotic prescriptions.

Key finding: Pyuria (leukocytes in urine) does not reliably distinguish between asymptomatic bacteriuria (ASB) and symptomatic UTI 3. The presence of leukocytes can occur with:

• Asymptomatic bacteriuria (2-7% of pregnant women)
• Vaginal contamination
• Physiologic changes of pregnancy
• Non-infectious inflammation

Recommended Evaluation Algorithm

For Asymptomatic Pregnant Women:

1. Screen with urine culture at an initial prenatal visit (not dipstick) 3

   • This is a strong recommendation based on moderate-quality evidence
   • Dipstick testing has unacceptably high false-negative rates (19.4-52.8%) that miss significant bacteriuria 4

2. If culture shows ≥100,000 CFU/mL: Treat ASB with 4-7 days of antibiotics 3

   • Preferred agents: nitrofurantoin, ampicillin, or cephalexin
   • Treatment reduces pyelonephritis risk from 20-35% to 1-4%
   • Reduces preterm birth and low birth weight

3. Do not treat based on dipstick alone in asymptomatic women

   • Only 6.8% of positive dipsticks had confirmed UTI on culture 2
   • 83.2% of women prescribed nitrofurantoin based on dipstick had negative cultures 2

For Symptomatic Pregnant Women:

If the patient has dysuria, frequency, urgency, suprapubic pain, or fever:

1. Obtain urine culture immediately
2. Consider empiric treatment while awaiting culture if:
   • Fever present (concern for pyelonephritis)
   • Severe symptoms
   • Risk factors for complicated infection
3. Adjust antibiotics based on culture results at 48-72 hours

Critical Pitfalls to Avoid

• Do not treat leukocyte esterase positivity alone: This leads to massive antibiotic overuse—83% of treated women in one study had no actual infection 2

• Do not rely on nitrite alone: While more specific (92-100%), nitrite has very poor sensitivity (19-48%) 1, missing 40-65% of true infections 5, 6

• Do not use urinalysis for screening: Microscopic examination for leukocytes has even worse performance (25% sensitivity) than dipstick 6

• Avoid symptom-based testing without culture: The 2024 guidelines emphasize that symptom-based testing is key to prevent misuse of antibiotics for ASB 1, but culture confirmation remains essential

Why This Matters for Outcomes

Untreated ASB in pregnancy leads to:

• Pyelonephritis: 20-35% risk if untreated vs. 1-4% if treated 3
• Preterm birth: Baseline risk 53/1000 reduced to 14/1000 with treatment 3
• Low birth weight: Risk reduced from 137/1000 to 88/1000 3

However, overtreatment based on false-positive dipsticks causes:

• Unnecessary antibiotic exposure to mother and fetus
• Antimicrobial resistance
• Adverse drug effects
• Healthcare costs

The bottom line: Culture-based screening and treatment of ASB in pregnancy is evidence-based and saves lives. Dipstick testing leads to both missed infections and massive overtreatment—it should not guide clinical decisions in pregnancy.